Lexagene Holdings Inc

Lexagene takes big step forward by now being recognized by FDA and CDC

Lexagene Holdings (CVE: LXG-OTCQB-LXXGF) CEO and Co-Founder Dr Jack Regan joined Steve Darling from Proactive Investors Vancouver to talk about the company now being recognized by the Food and Drug Administration and the US Centre for Disease control.

Regan discussed what this means for the company moving forward and what their timeline looks like for commercialization.

Quick facts: Lexagene Holdings Inc

Price: $0.64

Market: TSX-V
Market Cap: $45.79 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lexagene Holdings Inc named herein, including the promotion by the Company of Lexagene Holdings Inc in any Content on the Site, the Company...



Full interview: Lexagene Develops technology to test for deadly mosquito...

Lexagene (CVE: LXG-OTCQB-LXXGF) Founder and CEO Dr jack Regan joined Steve Darling from Proactive Vancouver on Skype with news the company has used their proprietary technology to develop a detection system for the Eastern Equine Encephalitis or EEE. Regan says that not only can they use the...

1 day, 12 hours ago

2 min read